Aug 24, 2012

Senior Internal Auditor for Large Pharmaceutical Company

Email this job



Blue Player Job OverviewCompany: Robert Half Finance & Accounting U.S.Location: US-NJ-WoodbridgeBase Pay: $75,000 - $90,000 /YearEmployee Type: Full-TimeIndustry: Accounting - Finance
Banking - Financial ServicesManages Others: Not SpecifiedJob Type: Accounting
FinanceReq'd Education: 4 Year DegreeReq'd Experience: At least 2 year(s)Req'd Travel: Not SpecifiedRelocation Covered: Not Specified Contact: RecruiterPhone: 732-634-7200Fax: 732-634-1574 Ref ID: 02720-114878 Job DescriptionClassification:  Auditor - Internal

Compensation:  $75,000.00 to $90,000.00 per year

My client is a Global leader in the Pharmaceutical Industry located in Central New Jersey is looking for a Senior Internal Auditor. This is an excellent opportunity to transition from public accounting in to a fortunes 50 company. They offer a great track from audit to management roles in finance and accounting throughout the organization.. Responsibilities include but are not limited to;
Lead small teams of auditors on various assignments.
Incumbent will be expected to lead complex, large and/or sensitive audits with limited management supervision in addition to actively participating in the audit and performing audit work
Overall responsibility for the preparation and qualify of work papers for the team.
Complete audit programs and work papers within the parameters set forth for performing audit work
Expected to meet deadlines as set forth by Corporate Audits Policies and Procedures and comply with established internal and external work paper standards and procedures
Apply elements of the Corporate Audit Group Vision and Values to assist in maintaining a strong internal control environment throughout the organization
Support Corporate Audit Management in the sharing of best practices and establishment of a best practices database that will support line management in practices across geographical areas.

If you're interested, please e-mail your resume to Richard.

View the Original article

No comments: